New hope for aggressive brain cancer: trial tests immune therapy combinations
NCT ID NCT06061809
Summary
This study is testing several combination treatments for adults whose glioblastoma brain cancer has returned or progressed after initial treatment. The trial has two parts: one testing three drugs together, and another comparing two different combinations that include a special cap that delivers electric fields to the tumor area. The main goals are to see if these treatments are safe and if they can help control the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chan Soon-Shiong Institute for Medicine (CSSIFM)
NOT_YET_RECRUITINGEl Segundo, California, 90245, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hoag Memorial Hospital Presbyterian
RECRUITINGNewport Beach, California, 92663, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Providence Medical Foundation
RECRUITINGFullerton, California, 92835, United States
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt-Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.